Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

With a volume of 12,212,671, the price of MRK is down -1.44% at $88.38. RSI indicators hint that the underlying stock may be ...

More than 50 years ago, concerns about Canada's dependence on the U.S. led to a policy discussion centred on what became ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

As more cancers are being linked to the human papillomavirus (HPV), including cancers showing up in younger-than-average patients, a local doctor is promoting the use of the HPV vaccine, which is ...

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft ...

The purpose of the prophylactic HPV vaccines is to induce antibodies to the specific vaccine-relevant HPV types that will be sustained for the duration of time the woman is susceptible to HPV ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

Here is what we know about polio as a disease, its vaccines and the likely number of lives saved through inoculation.

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...